Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tuya Pal

Showing results (61-70 of 171) with videos related to

Pageof 18
Sort By:
Cancer Medicine|March 8, 2026
Factors Associated With Inaccurate Recall of Inherited Cancer Genetic Test Results Among Individuals With Germline Pathogenic VariantsDeborah L Cragun, Brittany F Sears, Karishma Prakash Bharwani, et al.
Patient Education and Counseling|January 18, 2021
Sharing genetic test results with family members of BRCA, PALB2, CHEK2, and ATM carriersMarleah Dean, Ann L Tezak, Sabrina Johnson, et al.
American Journal of Medical Genetics|November 29, 2002
Spectrum of dolichospondylic dysplasia: two new patients with distinctive findingsAlison M Elliott, John M Graham, Cynthia J R Curry, et al.
The Breast Journal|April 23, 2020
Acceptability and outcomes of multigene panel testing among young Black breast cancer survivorsClaire C Conley, Jennifer D Garcia, Cristi Radford, et al.
Journal of Community Genetics|October 4, 2017
Preferences for multigene panel testing for hereditary breast cancer risk among ethnically diverse BRCA-uninformative familiesBelinda Vicuña, Harold D Delaney, Kristina G Flores, et al.
Cancers|July 27, 2022
Racial/Ethnic Disparities in Mortality Related to Access to Care for Major Cancers in the United StatesFei Wang, Xiang Shu, Tuya Pal, et al.
Genetic Testing and Molecular Biomarkers|March 2, 2013
A statewide survey of practitioners to assess knowledge and clinical practices regarding hereditary breast and ovarian cancerTuya Pal, Deborah Cragun, Courtney Lewis, et al.
Hereditary Cancer in Clinical Practice|January 17, 2026
Decisional conflict in women with a BRCA1 or BRCA2 pathogenic variant who have not elected for risk-reducing salpingo-oophorectomyKelly A Metcalfe, Anita Y Kinney, Steven A Narod, et al.
The Breast Journal|January 17, 2013
Early onset breast cancer in a registry-based sample of African-american women: BRCA mutation prevalence, and other personal and system-level clinical characteristicsTuya Pal, Devon Bonner, Jongphil Kim, et al.
JAMIA Open|November 10, 2021
Follow-up Interactive Long-Term Expert Ranking (FILTER): a crowdsourcing platform to adjudicate risk for survivorship careAlex C Cheng, Li Wen, Yanwei Li, et al.
Pageof 18

Showing results (61-70 of 171) with videos related to

Sort By:
Pageof 18
Cancer Medicine|March 8, 2026
Factors Associated With Inaccurate Recall of Inherited Cancer Genetic Test Results Among Individuals With Germline Pathogenic VariantsDeborah L Cragun, Brittany F Sears, Karishma Prakash Bharwani, et al.
Patient Education and Counseling|January 18, 2021
Sharing genetic test results with family members of BRCA, PALB2, CHEK2, and ATM carriersMarleah Dean, Ann L Tezak, Sabrina Johnson, et al.
American Journal of Medical Genetics|November 29, 2002
Spectrum of dolichospondylic dysplasia: two new patients with distinctive findingsAlison M Elliott, John M Graham, Cynthia J R Curry, et al.
The Breast Journal|April 23, 2020
Acceptability and outcomes of multigene panel testing among young Black breast cancer survivorsClaire C Conley, Jennifer D Garcia, Cristi Radford, et al.
Journal of Community Genetics|October 4, 2017
Preferences for multigene panel testing for hereditary breast cancer risk among ethnically diverse BRCA-uninformative familiesBelinda Vicuña, Harold D Delaney, Kristina G Flores, et al.
Cancers|July 27, 2022
Racial/Ethnic Disparities in Mortality Related to Access to Care for Major Cancers in the United StatesFei Wang, Xiang Shu, Tuya Pal, et al.
Genetic Testing and Molecular Biomarkers|March 2, 2013
A statewide survey of practitioners to assess knowledge and clinical practices regarding hereditary breast and ovarian cancerTuya Pal, Deborah Cragun, Courtney Lewis, et al.
Hereditary Cancer in Clinical Practice|January 17, 2026
Decisional conflict in women with a BRCA1 or BRCA2 pathogenic variant who have not elected for risk-reducing salpingo-oophorectomyKelly A Metcalfe, Anita Y Kinney, Steven A Narod, et al.
The Breast Journal|January 17, 2013
Early onset breast cancer in a registry-based sample of African-american women: BRCA mutation prevalence, and other personal and system-level clinical characteristicsTuya Pal, Devon Bonner, Jongphil Kim, et al.
JAMIA Open|November 10, 2021
Follow-up Interactive Long-Term Expert Ranking (FILTER): a crowdsourcing platform to adjudicate risk for survivorship careAlex C Cheng, Li Wen, Yanwei Li, et al.
Pageof 18